Clinical Research Directory
Browse clinical research sites, groups, and studies.
Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
Sponsor: St Vincent's Hospital, Sydney
Summary
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Official title: Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Qualitative Stage
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2025-12-01
Completion Date
2026-11-30
Last Updated
2026-04-27
Healthy Volunteers
No
Conditions
Interventions
Semi-structured Interview
this t study will use qualitative methods to explore men's views of gynaecomastia from high-risk BCR PCa treatments (Stage 1) to inform attributes and levels for a later DCE to examine patient treatment preferences (Stage 2).
Locations (1)
Kinghorn Cancer Centre
Sydney, New South Wales, Australia